Growth Metrics

Tandem Diabetes Care (TNDM) Profit After Tax (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,362.31%
Dec 31, 2025 97.22%
Sep 30, 2025 59.61%
Jun 30, 2025 59.86%
Mar 31, 2025 -17,392.19%
Dec 31, 2024 103.25%
Sep 30, 2024 24.54%
Jun 30, 2024 27.86%
Mar 31, 2024 -42.37%
Dec 31, 2023 8.98%
Sep 30, 2023 7.87%
Jun 30, 2023 71.12%
Mar 31, 2023 -681.43%
Dec 31, 2022 67.63%
Sep 30, 2022 -225.25%
Jun 30, 2022 -2.32%
Mar 31, 2022 -236.15%
Dec 31, 2021 86.54%
Sep 30, 2021 44.56%
Jun 30, 2021 179.46%
Mar 31, 2021 -129.67%
Dec 31, 2020 280.70%
Sep 30, 2020 65.29%
Jun 30, 2020 -82.33%
Mar 31, 2020 -660.60%
Dec 31, 2019 191.42%
Sep 30, 2019 -91.87%
Jun 30, 2019 93.42%
Mar 31, 2019 -723.77%
Dec 31, 2018 110.76%
Sep 30, 2018 42.31%
Jun 30, 2018 -81.56%
Mar 31, 2018 -186.63%
Dec 31, 2017 28.86%
Sep 30, 2017 26.45%
Jun 30, 2017 8.37%
Mar 31, 2017 -60.52%
Dec 31, 2016 50.29%
Sep 30, 2016 -62.69%
Jun 30, 2016 10.54%
Mar 31, 2016 -69.40%
Dec 31, 2015 38.25%
Sep 30, 2015 -0.27%
Jun 30, 2015 7.90%
Mar 31, 2015 -14.86%
Dec 31, 2014 7.22%
Sep 30, 2014 -3.67%
Jun 30, 2014 12.59%
Mar 31, 2014 7.00%
Dec 31, 2013 -80.80%
Sep 30, 2013 14.64%
Jun 30, 2013 -37.07%